Becton Dickinson Investors Seek Final OK Of $9M Deal

By Sydney Price · July 22, 2025, 11:55 PM EDT

Investors in medical tech manufacturer Becton Dickinson are seeking final approval of their $9 million deal that will end derivative claims the company was damaged by its attempts to hide regulatory...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE BECTON, DICKINSON AND COMPANY STOCKHOLDER DERIVATIVE LITIGATION

Case Number

2:20-cv-15474

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

November 02, 2020